Try GOLD - Free
The American Investor Taking On Swatch's Founding Family
Mint Hyderabad
|June 19, 2025
Wood published research that shows that family-owned businesses outperform the market over time
When American fund manager Steven Wood set his sights on the storied Swiss watchmaker Swatch Group, he tried a suitably stylish opening gambit. He sent Chief Executive Nick Hayek cigars; a favorite book, "The Luxury Strategy" by Jean-Noël Kapferer and Vincent Bastien; and a handwritten note laying out opportunities he saw for Swatch's luxury brands to recapture market share.
Over coffee, Wood says they discussed marketing strategies, particularly for the high-end brands, and how the company, known for its minimal contact with investors, should share more information.
Wood swapped out a Patek Philippe as his everyday watch in favor of a secondhand Breguet Classique. Within days of the October meeting, he invested more than one-quarter of his $150 million fund into the Swiss company, for around a 0.5% stake.
But the courtship abruptly ended in March, when Wood submitted himself as a board candidate to represent Swatch's minority shareholders.
Sales at Swatch had grown for years thanks to the popularity of its chic brands like Breguet, Blancpain and Omega, but since founder Nicolas G. Hayek's death in 2010, its high-end offerings have lost market share. Last year sales plunged in China, one of its most important markets, and the company's stock is now one of the most-shorted in Europe.
Wood, who runs investment firm GreenWood Investors, reached out to Nick Hayek, the founder's son, in September. The next month, the New York-based investor secured a meeting with the CEO and the finance chief at Swatch's timber-framed headquarters in Biel, Switzerland, where they talked for more than two hours
This story is from the June 19, 2025 edition of Mint Hyderabad.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Hyderabad
Mint Hyderabad
Nvidia, Eli Lilly to invest $1 bn in AI lab
Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.
1 min
January 13, 2026
Mint Hyderabad
Shadowfax IPO to open next week
Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.
1 min
January 13, 2026
Mint Hyderabad
The US climate cop-out should galvanize others
America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US
2 mins
January 13, 2026
Mint Hyderabad
Toyota pushes for fuel norm clarity
The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.
1 min
January 13, 2026
Mint Hyderabad
Food effect lifts Dec CPI inflation
India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.
1 min
January 13, 2026
Mint Hyderabad
Commissions trump advice in wealth management biz
surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.
2 mins
January 13, 2026
Mint Hyderabad
The Chinese company taking on the world's memory-chip giants
As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders
4 mins
January 13, 2026
Mint Hyderabad
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Hyderabad
Fix GST on capital goods to revive private investment
India faces a paradox today.
3 mins
January 13, 2026
Mint Hyderabad
Feeling tired? It could be too many messages
The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes
4 mins
January 13, 2026
Listen
Translate
Change font size
